scorecardresearch
Add as a preferred source on Google
Monday, October 13, 2025
HomeHealth

Health

Obesity care in India is evolving—no longer just diets & surgery, it’s all about multi-specialty approach

As obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised multidisciplinary treatments, at a cost.

Delhi HC orders examination into weight loss drug combinations, asks DCGI to seek expert consultation

The proceedings follow a PIL seeking a ban on sale of weight loss drugs that are still undergoing clinical trials internationally. The court asked DCGI to submit report within 3 months.

Shefali Jariwala’s death spotlights world of anti-ageing treatments built on big claims, little science

Anti-ageing treatments include broad spectrum of substances—from antioxidant supplements & growth hormone boosters, to testosterone therapy, among other things.

Punjab MBBS students call off strike after govt agrees to address stipends & fee demands

The development was announced by Forum of Resident Doctors, Punjab. Over 2,000 students of govt medical colleges in Amritsar, Faridkot & Patiala had been protesting since 7 May.

Why loneliness is a problem, even if it’s not an epidemic

The idea that loneliness is an ‘epidemic’ is misleading and it draws us away from sustainable solutions, rather than toward them.

Govt considers low-dose emicizumab for haemophilia, trial finds it more effective than existing treatment

‘Miracle drug’ can cost Rs 13 lakh for haemophilia A patient annually, but reduced dose found efficacious & cost-effective in small trial. Larger trial is under way.

In battle for Indian anti-obesity market, Eli Lilly’s pre-filled pen on one side, Novo Nordisk’s on other

India's anti-obesity drug market is currently valued at Rs 3,000-3,500 crore & is projected to grow nearly eightfold by 2030, according to market estimates.

Lancet report highlights gaps in immunisation—no routine vaccine for 14.4 lakh Indian kids in 2023

India after Nigeria recorded highest number of zero-dose children in 2023. The lack of immunisation against deadly diseases puts children at risk of life-threatening diseases.

Fat-busting blockbuster drug Wegovy launched in India, in pre-filled pens that can be self-administered

Danish pharma giant Novo Nordisk’s announcement comes months after launch of another top selling obesity drug Mounjaro in India by US based pharma giant Eli Lilly & Company.

Eli Lilly announces trial results for world’s 2nd weekly insulin, aims for launch by year-end

New Delhi: There is excitement and hope in the insulin market the world over after U.S. based pharma giant Eli Lilly & Company on...

On Camera

Resetting Afghanistan ties is geopolitical need. Gandhis are showing their diplomatic ignorance

With two hostile neighbours in the immediate vicinity and one in the greater region, it is imperative that New Delhi forge alliances that can offer some stability.

Niti Aayog recommends fully decriminalising 12 offences under new I-T Act to ‘foster more trust’

Recommendations appear in Niti Aayog’s Tax Policy Working Paper Series–II. It says there is a need to shift away from fear-based enforcement to trust-based governance.

India, UK sign £350 mn deal for Martlet. What are these Lightweight Multirole Missiles

In service with the British military since 2019, it is also known as the Martlet missile. Ukrainians have also deployed these missiles against Russian troops.

CJI, IPS, IAS & Homebound: A wake-up call 75 years in the making

Education, reservations, govt jobs are meant to bring equality and dignity. That we are a long way from that is evident in the shoe thrown at the CJI and the suicide of Haryana IPS officer. The film Homebound has a lesson too.